Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Comparison of deep gray matter lesions on magnetic resonance imaging among adults with acute disseminated encephalomyelitis, multiple sclerosis, and neuromyelitis optica.
Involvement of Toso in activation of monocytes, macrophages, and granulocytes.
Longitudinally Extensive Transverse Myelitis With and Without Aquaporin 4 Antibodies.
A new model for primary-progressive multiple sclerosis?
Multiple sclerosis: Lessons from molecular neuropathology.
The prevalence of familial multiple sclerosis in saskatoon, Saskatchewan.
Relationship between Working Hours and Power of Attention, Memory, Fatigue, Depression and Self-Efficacy One Year after Diagnosis of Clinically Isolated Syndrome and Relapsing Remitting Multiple Sclerosis.
Two-photon imaging of remyelination of spinal cord axons by engrafted neural precursor cells in a viral model of multiple sclerosis.
Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination.
In vivo histology of the myelin g-ratio with magnetic resonance imaging.
A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.
Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease.
[Therapeutic plasma exchange: applications in neurology].
Peginterferon beta-1a (Plegridy) for multiple sclerosis.
Exercise in the management of persons with multiple sclerosis.
Neuro-Ophthalmic Syndromes and Processing Speed in Multiple Sclerosis.
Tumefactive demyelinating lesions as a first clinical event: Clinical, imaging, and follow-up observations.
How does magnetization transfer influence mcDESPOT results?
Multiple sclerosis and infections.
Differential targeting of IL-2 and T cell receptor signaling pathways selectively expands regulatory T cells while inhibiting conventional T cells.
Pathophysiology of immune-mediated demyelinating neuropathies - Part II: Neurology.
Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis.
Dual diagnosis: rheumatoid arthritis and multiple sclerosis.
Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells.
Meningoencephalitis as an initial manifestation of neuromyelitis optica spectrum disorder.
Pages
« first
‹ previous
…
373
374
375
376
377
378
379
380
381
…
next ›
last »